CBCC Global Research

In continuation to series of Whitepaper presentation on: India as a Preferred Destination for the Execution of Clinical Trials Here’s the second presentation on: Competitive Advantages of India in Clinical Trials, where we talk about: 2.1 A Large, Treatment-Naive Population 2.2 Cost Efficiency 2.3 Evolving Regulatory Framework o  Sugam Portal o  The Clinical Trial Registry of India (CTRI) o  Accelerated Approvals & Orphan Drug Exemptions o  Phase III Trial Exemptions 2.4 Advanced Medical Infrastructure and Access to Tier-1 Cities With a favorable regulatory environment and advanced healthcare infrastructure, India provides biopharma companies with a competitive edge in accelerating trial timelines and optimizing outcomes. CBCC having its direct presence in the US and India, learn how we are helping pharma and biotech companies bring the treatment to market faster! Please take a few moments to share some information with us on [email protected] and we will be in touch shortly. CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION    Manoj Vyas Dr. Sandeep Singh Jaimeen Vanparia Avanish Mishra, Ph.D. Sanjeev Ganatra Nikhil Gandhi Harakh Shah, PMP® Tapan Shah Kinnari Gandhi RQAP-GCP Dr. Praveen Choudhary Nikunj Patel Ankit Parikh Ajit Upadhyaya Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas   

CBCC Global Research is proud to announce successful completion of 2 USFDA inspections with ZERO 483 Indication: Iron Deficiency Anemia 2 Inspection sites in Vadodara, India (December, 2024)   CBCC Global Research: Benchmarked to Global Standards of Excellence Manoj Vyas Dr. Sandeep Singh Jaimeen Vanparia Avanish Mishra, Ph.D. Sanjeev Ganatra Nikhil Gandhi Harakh Shah, PMP® Tapan Shah Kinnari Gandhi RQAP-GCP Dr. Praveen Choudhary Nikunj Patel Ankit Parikh Ajit Upadhyaya Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas #USFDA #Inspection #CBCC #Quality #Compliance

We are pleased to launch series of Whitepaper Presentation on ‘India as a Preferred Destination for the Execution of Clinical Trials’ Here’s the first presentation on The Global Clinical Challenges and Opportunities, where we talk about: 1.1 USA: The Benchmark for Advanced Trials 1.2 Europe: Established but Facing Saturation 1.3 China: Rapid Growth but Lingering Regulatory Challenges 1.4 South Korea: Technological Prowess with Limitations 1.5 India: The Rising Contender India remains an unexplored territory regarding clinical research. Although India accounts for only 4% of global clinical trials, the country holds immense potential. CBCC having its direct presence in the US and India, learn how we are helping pharma and biotech companies bring the treatment to market faster! Please take a few moments to share some information with us on [email protected] and we will be in touch shortly. CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION Manoj Vyas Dr. Sandeep Singh Jaimeen Vanparia Avanish Mishra, Ph.D. Sanjeev Ganatra Nikhil Gandhi Harakh Shah, PMP® Tapan Shah Kinnari Gandhi RQAP-GCP Dr. Praveen Choudhary Nikunj Patel Ankit Parikh Ajit Upadhyaya Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas

We are pleased to announce the induction of Dr. Mark Kirschbaum as Chief Medical Officer at CBCC! Dr. Kirschbaum is a highly experienced hematologist/oncologist with over 30 years of experience in molecular medicine, new drug development, clinical trial design and patient care. We are confident that Dr. Kirschbaum, with his deep understanding of all facets of clinical development will help push our businesses to reach a new pinnacle. CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION Manoj Vyas Dr. Sandeep Singh Jaimeen Vanparia Avanish Mishra, Ph.D. Sanjeev Ganatra Nikhil Gandhi Harakh Shah, PMP® Tapan Shah Kinnari Gandhi RQAP-GCP Dr. Praveen Choudhary Nikunj Patel Ankit Parikh Ajit Upadhyaya Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas

Warmest wishes for a happy and blessed Thanksgiving. May your day be filled with happiness and peace! Manoj Vyas Dr. Sandeep Singh Jaimeen Vanparia Avanish Mishra, Ph.D. Sanjeev Ganatra Nikhil Gandhi Harakh Shah, PMP® Tapan Shah Kinnari Gandhi RQAP-GCP Dr. Praveen Choudhary Nikunj Patel Ankit Parikh Ajit Upadhyaya Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas

Join CBCC team members at The 66th ASH (American Society of Hematology) Annual Meeting and Exposition: 7 to 10 Dec. 2024, San Diego, CA. For more information about this conference, please visit: https://lnkd.in/dZFSGYur We will be glad to schedule an appointment with you to discuss your upcoming drug development plan and help you bring the treatment to market faster. For business appointments please email us at [email protected] CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION Manoj Vyas Dr. Sandeep Singh Jaimeen Vanparia Avanish Mishra, Ph.D. Sanjeev Ganatra Nikhil Gandhi Harakh Shah, PMP® Tapan Shah Kinnari Gandhi RQAP-GCP Dr. Praveen Choudhary Nikunj Patel Ankit Parikh Ajit Upadhyaya Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas

Orphan-drug designation (ODD) for treatment of malignant glioma received from USFDA! ODD application submitted by CBCC acting as a US agent for a China based biotech company Therapeutic Area : Oncology Scope : End-to-end IND regulatory consultancy services including preparation of ODD application CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION Manoj Vyas Dr. Sandeep Singh Jaimeen Vanparia Avanish Mishra, Ph.D. Sanjeev Ganatra Harakh Shah, PMP® Nikhil Gandhi Tapan Shah Kinnari Gandhi RQAP-GCP Dr. Praveen Choudhary Nikunj Patel Ankit Parikh Ajit Upadhyaya Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas

CBCC Global Research hosted an exclusive networking dinner with professional colleagues and engaged in an informal discussion focusing on how India is becoming a hub for innovative clinical research and development solutions, and Unlocking Capital Efficiency: Confidently Navigating Clinical Trials in India. It’s through collaborative endeavors that we can make a real difference in the clinical research community. CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION Manoj Vyas Dr. Sandeep Singh Jaimeen Vanparia Avanish Mishra, Ph.D. Sanjeev Ganatra Harakh Shah, PMP® Tapan Shah Kinnari Gandhi RQAP-GCP Dr. Praveen Choudhary Nikunj Patel Ankit Parikh Ajit Upadhyaya Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas

Sanjeev Ganatra will be at the upcoming American Academy of Optometry meeting from November 7-9th (Indianapolis) and looks forward to meeting with our client companies, site partners and clinical colleagues as we learn and discuss eye care and treatment innovation. Let us know if you will be there and we will reach out to meet. For business appointments please email us at [email protected] CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION Manoj Vyas Dr. Sandeep Singh Jaimeen Vanparia Avanish Mishra, Ph.D. Sanjeev Ganatra Harakh Shah, PMP® Tapan Shah Kinnari Gandhi Dr. Praveen Choudhary Nikunj Patel Ankit Parikh Ajit Upadhyaya Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas

CBCC Global Research has been selected as a finalist for the 2024 Fierce CRO Awards in 2 categories by Fierce Biotech!   Category 1: Excellence in Global Operations - Celebrates CROs that effectively manage and execute global research projects, demonstrating expertise in navigating diverse regulatory environments and operational challenges.   Category 2: Excellence in Clinical Trial Management - Recognizes CROs that demonstrate superior management of clinical trials, including exceptional planning, execution, and oversight, resulting in successful trial outcomes.   Team CBCC is proud to be named among this strong group of global industry leaders. View the full list of finalists here: https://lnkd.in/dSnuCpcz CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION Manoj Vyas Dr. Sandeep Singh Jaimeen Vanparia Avanish Mishra, Ph.D. Sanjeev Ganatra Harakh Shah, PMP® Tapan Shah Kinnari Gandhi Dr. Praveen Choudhary Nikunj Patel Ankit Parikh Ajit Upadhyaya Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas